Fournier gangrene epidemiology and demographics

Revision as of 14:38, 21 September 2017 by Mmir (talk | contribs) (Category)
Jump to navigation Jump to search

Fournier gangrene Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Fournier gangrene from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Lupus and Quality of Life

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Fournier gangrene epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Fournier gangrene epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

National Guidelines Clearinghouse

NICE Guidance

FDA on Fournier gangrene epidemiology and demographics

on Fournier gangrene epidemiology and demographics

Fournier gangrene epidemiology and demographics in the news

Blogs onFournier gangrene epidemiology and demographics

Directions to Hospitals Treating Fournier gangrene

Risk calculators and risk factors for Fournier gangrene epidemiology and demographics

Steven C. Campbell, M.D., Ph.D.; Associate Editor(s)-in-Chief: Yamuna Kondapally, M.B.B.S[1]; Jesus Rosario Hernandez, M.D. [2]

Overview

The overall incidence of Fournier gangrene annually is 1.6 cases per 100,000 males. The incidence peaked and remained steady after age 50 at 3.3 cases per 100,000 males. Fournier gangrene affects individuals of all ages but more commonly affects individuals older than 50 years of age.[1][2]. Men are more commonly affected with Fournier gangrene than women, with a male:female ratio of 10:1.[3][2]. Mortality rate decreases with early aggressive treatment. The mortality rate of Fournier gangrene is between 20% to 80%. Higher mortality rates are found in daibetics, alcoholics and those with colorectal sources of infection.[4]

Epidemiology and Demographics

Incidence

Incidence of Fournier gangrene in the United states:[5]

  • The overall incidence of Fournier gangrene annually is 1.6 cases per 100,000 males. The incidence peaked and remained steady after age 50 at 3.3 cases per 100,000 males.
  • The incidence of Fournier gangrene increased 0.2 per 100,000 males for each 1% increase in the regional prevalence of diabetes.
  • The incidence rate was highest in the southern U.S. and lowest in the western and mid-western U.S.

Age

Fournier gangrene affects individuals of all ages but more commonly affects individuals older than 50 years of age.[1][2]

Gender

Men are more commonly affected with Fournier gangrene than women, with a male:female ratio of 10:1.[3][2]

Mortality

  • Mortality rate decreases with early aggressive treatment.
  • The mortality rate of Fournier gangrene is between 20% to 80%. Higher mortality rates are found in daibetics, alcoholics and those with colorectal sources of infection.[4]

References

  1. 1.0 1.1 Mallikarjuna MN, Vijayakumar A, Patil VS, Shivswamy BS (2012). "Fournier's Gangrene: Current Practices". ISRN Surg. 2012: 942437. doi:10.5402/2012/942437. PMC 3518952. PMID 23251819.
  2. 2.0 2.1 2.2 2.3 Shyam DC, Rapsang AG (2013). "Fournier's gangrene". Surgeon. 11 (4): 222–32. doi:10.1016/j.surge.2013.02.001. PMID 23578806.
  3. 3.0 3.1 Chennamsetty A, Khourdaji I, Burks F, Killinger KA (2015). "Contemporary diagnosis and management of Fournier's gangrene". Ther Adv Urol. 7 (4): 203–15. doi:10.1177/1756287215584740. PMC 4580094. PMID 26445600.
  4. 4.0 4.1 Moslemi MK, Sadighi Gilani MA, Moslemi AA, Arabshahi A (2009). "Fournier gangrene presenting in a patient with undiagnosed rectal adenocarcinoma: a case report". Cases J. 2: 9136. doi:10.1186/1757-1626-2-9136. PMC 2803933. PMID 20062653.
  5. 5.0 5.1 Sorensen MD, Krieger JN (2016). "Fournier's Gangrene: Epidemiology and Outcomes in the General US Population". Urol Int. 97 (3): 249–259. doi:10.1159/000445695. PMID 27172977.